New Zealand markets closed

Tiziana Life Sciences Ltd (TLSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6227-0.0173 (-2.70%)
At close: 04:00PM EDT
0.6011 -0.02 (-3.47%)
After hours: 07:15PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 62.46M
Enterprise value 56.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.70
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.98

Trading information

Stock price history

Beta (5Y monthly) -0.04
52-week change 3-21.52%
S&P500 52-week change 326.27%
52-week high 31.2700
52-week low 30.4100
50-day moving average 30.5526
200-day moving average 30.6082

Share statistics

Avg vol (3-month) 3184.87k
Avg vol (10-day) 3128.25k
Shares outstanding 5100.31M
Implied shares outstanding 6100.31M
Float 861.41M
% held by insiders 138.03%
% held by institutions 10.78%
Shares short (30 Apr 2024) 4394.13k
Short ratio (30 Apr 2024) 41.08
Short % of float (30 Apr 2024) 40.64%
Short % of shares outstanding (30 Apr 2024) 40.39%
Shares short (prior month 28 Mar 2024) 4322.15k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22499:1000
Last split date 331 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.64%
Return on equity (ttm)-90.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.77M
Net income avi to common (ttm)-19.5M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.6M
Total cash per share (mrq)0.07
Total debt (mrq)353k
Total debt/equity (mrq)2.66%
Current ratio (mrq)3.85
Book value per share (mrq)0.13

Cash flow statement

Operating cash flow (ttm)-19.09M
Levered free cash flow (ttm)-10.88M